FDAFDA · Food and drugs·Recall number D-1094-2023
Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05.
Published August 30, 2023 · Recall initiated: August 10, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.
What to do
Voluntary: Firm initiated
Recall details
- Manufacturer
- Imprimis NJOF, LLC
- Distributor
- Nationwide in the US
- Lot
- Lot #s: 22DEC047 exp 9/16/23, 23FEB057 exp 11/24/23.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.